Boehringer-Mannheim Report issue

For profit
Founded: Stuttgart Germany (1817)
Status: Acquired by Roche (1997)

Organization Overview

First Clinical Trial
1999
NCT00002385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Boehringer Mannheim

Active Ingredients

Drugs in Other Trials (1)

fozivudine tidoxil (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1